PRVA

Privia Health Group, Inc. (PRVA) - Q3 2025 10-Q Summary

Business Context and Reporting Period

This report covers the quarterly period ended September 30, 2025. Privia Health Group, Inc. is a technology-driven, national physician-enablement company operating in 16 markets across the United States. The company utilizes a unique practice model combining regional medical groups with provider autonomy, offering both Fee-for-Service (FFS) and Value-Based Care (VBC) solutions. As of the reporting date, the company had 5,250 Implemented Providers and 1.406 million Attributed Lives.

Key Financial Metrics

Liquidity and Debt: The company holds $441.4 million in cash and cash equivalents. It maintains a $125 million senior secured revolving credit facility with Wells Fargo, with no outstanding borrowings as of September 30, 2025.

Material Changes vs. Prior Period

• Revenue Growth: Revenue increased 32.5% year-over-year in Q3 2025, driven by a 24.5% increase in FFS-patient care, a 70.3% surge in Capitated revenue, and a 68.6% jump in Shared savings revenue.
• Profitability Expansion: Operating income more than doubled (147.8% increase) to $14.4 million in Q3 2025. Net income attributable to Privia increased 94.1% to $6.9 million.
• Acquisition Impact: The company entered the Arizona market in April 2025 via the acquisition of PMG-AZ, contributing $37.0 million in revenue from the acquisition date through quarter-end. This acquisition also drove a significant increase in amortization expenses.
• Provider Liability: Provider liability increased to $495.7 million (from $364.6 million at year-end 2024), reflecting growth in provider expenses and claims incurred under at-risk capitation arrangements.
• Stock-Based Compensation: Total stock-based compensation expense rose to $19.0 million in Q3 2025 (from $15.1 million in Q3 2024), impacting operating expenses.

Guidance, Outlook, and Risks

Management Commentary: Management attributes growth to organic expansion, the addition of new providers (13.1% increase), and the successful entry into Indiana and Arizona markets. The company continues to shift markets toward Value-Based Care (VBC), with VBC revenue now representing 33.1% of total revenue in Q3 2025.

Subsequent Events:

• In October 2025, the company received $156.9 million from CMS for 2024 MSSP shared savings.
• On September 23, 2025, Privia agreed to acquire an ACO business from Evolent Health, Inc. for $100 million in cash plus up to $13 million in earn-outs, expected to close in Q4 2025.

Risks and Contingencies:

• Regulatory Environment: Heavy reliance on government payers (15% of revenue) and complex healthcare regulations pose risks to reimbursement rates and operational compliance.
• Concentration Risk: Three major payers accounted for 66% of total revenue in Q3 2025. Payer A alone represented 28% of revenue.
• Technology Dependence: Operations rely heavily on third-party vendors, specifically athenahealth for EMR services.
• Valuation Adjustments: The Arizona acquisition includes up to $25 million in contingent consideration based on future performance targets.

Investor Verification Checklist

• Shared Savings Accruals: Verify the sustainability of the $23.8 million revenue adjustment in Q3 related to the change in estimate for Shared Savings accruals.
• Acquisition Integration: Monitor the integration progress and revenue contribution of the Arizona (PMG-AZ) and Indiana acquisitions.
• Payer Concentration: Assess the risk exposure to the top three payers, which collectively represent two-thirds of revenue.
• Provider Liability Estimates: Review the actuarial assumptions used to estimate the $495.7 million provider liability, particularly regarding at-risk capitation claims.
• Upcoming M&A: Track the regulatory approval and closing timeline for the proposed $100 million acquisition of the Evolent Health ACO business.